Celgene, Cornell University deal

CELG and Cornell will evaluate the molecular mechanism by which CELG’s Thalomid thalidomide and IMiDs (immunomodulatory drugs) regulate cyclooxgenase-2 ( COX-2) expression, which is known to play a r...